JTJaakko Tuomilehto

Jaakko Tuomilehto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jaakko Tuomilehto has a total of 641 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic integration reveals causal effects of chromatin accessibility on nucleosome positioning across diverse muscle cells

    by Xiaoou Wang, Catherine C. Robertson, Arushi Varshney, Nandini Manickam, Peter Orchard, Markku Laakso, Jaakko Tuomilehto, Timo A. Lakka, Karen L. Mohlke, Michael Boehnke, et al.

  • Open Access

    Correction: Enani et al. The Association Between Dyslipidemia, Dietary Habits and Other Lifestyle Indicators Among Non-Diabetic Attendees of Primary Health Care Centers in Jeddah, Saudi Arabia. Nutrients 2020, 12, 2441

    by Sumia Enani, Suhad Bahijri, Manal Malibary, Hanan Jambi, Basmah Eldakhakhny, Jawaher Al-Ahmadi, Rajaa Al Raddadi, Ghada Ajabnoor, Anwar Boraie, Jaakko Tuomilehto

    The authors wish to make the following corrections to the published article

  • Open Access

    Correction: Eldakhakhny et al. Prevalence and Factors Associated with Metabolic Syndrome Among Non-Diabetic Saudi Adults: A Cross-Sectional Study. Biomedicines 2023, 11, 3242

    by Basmah Eldakhakhny, Sumia Enani, Hanan Jambi, Ghada Ajabnoor, Jawaher Al-Ahmadi, Rajaa Al-Raddadi, Lubna Alsheikh, Wesam H. Abdulaal, Hoda Gad, Anwar Borai, et al.

  • Open Access

    A comparison of anthropometric indicators in predicting the incidence of diabetes and intermediate hyperglycaemia in Finland: a 22-year observational study

    by Julia Lybeck, Jaakko Tuomilehto, Jouko Saramies, Markku Koiranen, Hannu Uusitalo, Sirkka Keinänen-Kiukaanniemi, Kadri Suija

    Given the rising global prevalence of obesity and its strong association with type 2 diabetes, this study aims to evaluate the comparative effectiveness of various anthropometric indicators in predicting the incidence of type 2 diabetes and intermediate hyperglycaemia (IH) over a 22-year period. Due to the limitations of body mass index as a predictive marker, the study assesses alternative metrics, including waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), waist circumference (WC), and relative fat mass (RFM), to determine their predictive power for type 2 diabetes and intermediate hyperglycaemia. The cohort comprised 1168 adults (aged ≥ 50 years) from Savitaipale, Finland. Data collection included clinical and laboratory assessments and questionnaires at baseline and at the 10-, and 22-year follow-ups. The incidence of type 2 diabetes and IH was assessed via a 2-h oral glucose tolerance test and health care registry data. Receiver operating characteristic (ROC) curves and area under the curve (AUC) metrics were used to evaluate the predictive power of each indicator, stratified by sex. WHR had the highest predictive accuracy for type 2 diabetes in men (AUC = 0.70), whereas RFM and WHtR were equally predictive in women (AUC = 0.68). For IH, RFM and WHR were most predictive in men, and WHtR in women. Combining multiple indicators improved the sensitivity of type 2 diabetes prediction. Alternative anthropometric indicators offer comparable predictive value and show potential for individualised type 2 diabetes and IH risk assessment. Sex-specific cutoffs and a multi-indicator approach could be used to improve screening and early intervention strategies, potentially improving public health management of diabetes risk.

  • Open Access

    Exploring the association between ceramide, phosphatidylcholine, and COPD prevalence and incidence: a FINRISK population-based cohort study

    by Mohammadreza Shoghli, Juha Sinisalo, A. Inkeri Lokki, Mitja Lääperi, Marja-Liisa Lokki, Mika Hilvo, Antti Jylhä, Jaakko Tuomilehto, Reijo Laaksonen

    Background: Ceramides (Cers) and phosphatidylcholines (PCs) are potential lipid biomarkers in obstructive pulmonary disease (COPD). Even though they are linked to inflammation and lipid dysregulation, little is known about how these factors affect the prevalence and incidence of COPD in population-based cohorts. This study investigates these associations, addressing knowledge gaps regarding the interplay of Cers, PCs, and COPD risk, focusing on sex-specific differences and smoking. Methods: This observational study analysed data from the population-based FINRISK 2002 cohort, with 7,722 participants for prevalence and 7,662 for incidence analyses. Logistic regression models were used to assess associations between lipid biomarkers and prevalent COPD, while Cox regression models were applied for incident COPD. CERT1 and CERT2 (Cardiovascular Event Risk Test 1 and 2) are lipid-based scores derived from ceramide (Cer) ratios that estimate cardiovascular risk; in this study, they were used to examine their association with COPD. Kaplan-Meier curves were used to evaluate the impact of CERT scores on COPD risk, stratified by smoking status. Results: Elevated CERT1 and CERT2 scores were associated with both prevalent and incident COPD. For CERT1, the association with prevalent COPD was significant (univariable OR = 1.81, 95% CI: 1.41–2.33, p = < 0.001), as was the association with incident COPD (univariable HR = 1.33, 95% CI: 1.16–1.53, p = < 0.001). CERT2 was also significantly associated with prevalent COPD (adjusted OR = 1.57, 95% CI: 1.15–2.16, p = 0.005) and with incident COPD (univariable HR = 1.53, 95% CI: 1.32–1.77, p = < 0.001). PC species (14:0/22:6) was significantly associated with a lower risk of incident COPD (adjusted HR = 0.85, 95% CI: 0.73–0.98, p = 0.023). The Cer(d18:1/18:0)/PC (14:0/22:6) ratio was associated with both prevalent COPD (adjusted OR = 1.37, 95% CI: 1.01–1.86, p = 0.041) and incident COPD (HR = 1.24, 95% CI: 1.07–1.44, p = 0.004). Smokers had an elevated risk of COPD with increasing CERT scores. Conclusion: These findings support the role of lipid biomarkers, particularly Cers and CERT scores, in improving COPD risk prediction and management, with potential implications for targeted interventions in smokers.


  • Open Access

    Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracy

    by Jorge Acosta-Reyes, Diana Patricia Rodríguez Garrido, Tania Acosta Vergara, Pablo Aschner, Cristina Alejandra Fraga, Aitana Vazquez-Fernandez, Jaakko Tuomilehto, Rafael Gabriel


  • Open Access

    Competing Risks Analysis of the Finnish Diabetes Prevention Study

    by Moustafa M. A. Ibrahim, Matti Uusitupa, Jaakko Tuomilehto, Jaana Lindström, Maria C. Kjellsson, Mats O. Karlsson

    Clinical studies often observe one interesting event in the presence of other competing events. When both types of events can occur at any time but are only observed at clinical visits (i.e., interval censored), standard survival models may introduce bias in the estimated incidence of the interesting event over time. This can also lead to inflated relative differences between treatment groups. We developed a multi‐state model for competing risks analysis of interval censored data from the Finnish Diabetes Prevention Study. The developed model predicted the participants' clinical outcomes and demonstrated that lifestyle changes significantly decreased the risk of both diabetes and death. The model showed that those who dropped out were at lower risk of developing diabetes, neglecting the assumption of independent censoring. Furthermore, the model identified the most important covariates predicting the future development of diabetes, which should be targeted for therapeutic intervention in likely clinical scenarios. These covariates are baseline BMI, HbA1c, and insulin sensitivity measurements by QUICKI for the onset of developing T2DM, baseline BMI for dropping out, and sex and age as the predictive covariates of death.Trial Registration: ClinicalTrials.gov identifier: NCT00518167


  • Open Access

    Insulin sensitivity and beta-cell function in healthy Vietnamese adults: Insights from HOMA2 analysis

    by Tung Do Dinh, Linh Nguyen Phuong, Bình Ta Van, Jaakko Tuomilehto, Tuan Tran Ngoc, Thuan Nguyen Van, Xuan Thanh Nguyen

    Background: Insulin sensitivity impairment and beta-cell function defects are involved in type 2 diabetes and other metabolic diseases. Objective: This study aimed to estimate the range of insulin sensitivity and beta-cell function among healthy Vietnamese adults. Methods: The data were collected from 51 healthy adults (17 men, 34 women; mean age 26.7 ± 4.7 years). All participants were free from diabetes, other major diseases, and associated risk factors. All participants had a normal fasting plasma glucose level, BMI, serum insulin and lipid levels, oral glucose tolerance test results, waist circumference, and family history. Beta-cell function and insulin sensitivity were calculated using the HOMA2 Calculator version 2.2. Results: The beta-cell function, insulin sensitivity, and insulin resistance indices were 90.1 ± 21.7, 178.4 ± 58.9, and 0.63 ± 0.20, respectively, for both plasma glucose and insulin concentrations and 237.6 ± 44.8, 41.3 ± 8.7, and 2.53 ± 0.53, respectively, for both plasma glucose and C-peptide concentrations. Beta-cell function was lower in men than in women (p < 0.05). Beta cell function showed a significant inverse correlation with insulin sensitivity. The total/HDL cholesterol ratio was significantly inversely correlated with insulin sensitivity and significantly directly correlated with insulin resistance. However, no significant correlations were found between beta cell function; insulin sensitivity; the insulin resistance index; or total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), or high-density lipoprotein cholesterol (HDL-C) among healthy Vietnamese adults. Conclusions: In healthy Vietnamese adults, insulin sensitivity was strongly correlated with beta cell function and high-density lipoprotein cholesterol (HDL-C) levels. This study provides important insights into the normal range of insulin sensitivity and beta-cell function among healthy Vietnamese adults.


  • Open Access

    Association of ceramide risk scores with rheumatoid arthritis: a FINRISK population-based cohort study

    by Mohammadreza Shoghli, Juha Sinisalo, A. Inkeri Lokki, Mitja Lääperi, Marja-Liisa Lokki, Mika Hilvo, Antti Jylhä, Jaakko Tuomilehto, Reijo Laaksonen

    Objectives This study aimed to explore the association between lipid-based Cardiovascular Event Risk Tests (CERT1 and CERT2), including ceramides (Cer) and phosphatidylcholine (PC) lipid species, and rheumatoid arthritis (RA), an inflammatory disease that can increase the risk of cardiovascular diseases. Design Prospective population-based cohort study. Setting Primary care centres across five geographical areas in Finland. Methods The study included 7702 individuals (selected from the FINRISK cohort) who were assessed for the prevalence and incidence of RA. At baseline, the cohort included 7518 RA-free individuals, among whom 329 developed RA during the study, and 184 had a history of RA at baseline. Serum levels of ceramides and PC were measured using mass spectrometry, and CERT scores were calculated. Main outcome measures Prevalence and incidence of RA, CERT scores, and serum lipid levels. Results CERT scores were associated with prevalent RA but not with incident RA in the full cohort. Adjusted ORs and 95% CI for prevalent RA were 1.24 (95% CI 1.05 to 1.46) for CERT1 and 1.42 (95% CI 1.20 to 1.68) for CERT2. Stratified analyses showed that these associations were consistent among individuals over 50 years of age and across both sexes. The Cer (d18:1/16:0)/PC (16:0/22:5) ratio was significantly associated with RA in younger individuals (OR 1.66; 95% CI (1.26 to 2.18)). Overall, the association between lipids and RA was stronger in women than men. Conclusions The study shows a significant association between prevalent RA and bioactive lipid species used for cardiovascular risk assessment. These findings emphasise the importance of considering residual inflammatory risks, such as RA, in cardiovascular risk evaluations in clinical settings.


  • Open Access

    Oxidative stress and inflammation on metabolic abnormalities and renal involvement in prediabetic subjects across Europe

    by Sebastián Mas-Fontao, Esther Civantos, Nisa Boukichou-Abdelkader, Manuel Soto-Catalan, Marta Romeo-Colas, Arantxa Marco, Carmen Gomez-Guerrero, Juan Antonio Moreno, Jaakko Tuomilehto, Rafael Gabriel, et al.